(Q38232823)

31 August 2017

TYROBP in Alzheimer's disease (English)

1 reference

31 August 2017

0 references

Jin-Tai Yu

4

0 references

Lan Tan

series ordinal

3

object named as

Lan Tan

1 reference

31 August 2017

2

Teng Jiang

1 reference

31 August 2017

Jing Ma

1

1 reference

31 August 2017

23 July 2014

1 reference

31 August 2017

Molecular Neurobiology

1 reference

31 August 2017

51

1 reference

31 August 2017

2

1 reference

31 August 2017

820-826

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-014-8811-9

31 August 2017

0 references

cites work

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Microglia in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Microglia and neuroinflammation: a pathological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Apolipoprotein E in Alzheimer's disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

DAP12: an adapter protein with dual functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Activating and inhibitory functions of DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

TREMs in the immune system and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

DAP10- and DAP12-associated receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

DAP12 signaling: from immune cells to bone modeling and brain myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

TREM2 and the neuroimmunology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Regulation of innate immune responses in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Variant TREM2 as risk factor for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Immune activation in brain aging and neurodegeneration: too much or too little?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Activation of the classical complement pathway in brain tissue of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

The cell cycle in Alzheimer disease: a unique target for neuropharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Molecular networks as sensors and drivers of common human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Cutting Edge: TREM-2 Attenuates Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8811-9

Novel disease-modifying therapies for Alzheimer's disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25052481

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25052481

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12035-014-8811-9

1 reference

PubMed ID

25052481

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

25052481